Good results in pancreatic cancer treatment trials
Israel’s BioLineRx has announced encouraging initial results from its Phase 2a trials of its BL-8040 treatment on patients with metastatic pancreatic cancer. After only five days of treatment the treatment substantially increased the numbers of T-cells fighting the tumors.
This entry was posted in Israel's Medical Achievements
. Bookmark the permalink